Danielle M Burgenske - Van Andel Research Institute

基本信息

浏览量：4

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 75 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

In Vivo Selection of Anti-Glioblastoma DNA Aptamers in an Orthotopic Patient-Derived Xenograft Model

Caroline D Doherty, Brandon A Wilbanks,Sonia Jain, Keenan S Pearson, Katie K Bakken,Danielle M Burgenske, Nay Won Lett,Jann N Sarkaria, Louis J Maher

NAR cancerno. 1 (2025): zcaf005-zcaf005

引用0浏览0WOS引用

Modeling the Acute Mucosal Toxicity of Fractionated Radiotherapy Combined with the ATM Inhibitor WSD0628

Darwin A. Garcia,Sneha Rathi,Margaret A. Connors,Michael Grams,Rachael A. Vaubel,Katrina K. Bakken,Lauren L. Ott,Brett L. Carlson,Zeng Hu,Paul A. Decker,Jeanette E. Eckel-Passow,Danielle M. Burgenske, Wei Zhong, Joshua D. Trzasko,Michael G. Herman,William F. Elmquist,Nicholas B. Remmes,Jann N. Sarkaria

MOLECULAR CANCER THERAPEUTICSno. 2 (2025): 299-309

引用0浏览0WOS引用

Table S2 from Delivery Versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant in Vivo Efficacy in Glioblastoma

Wenjuan Zhang,Rachael A. Vaubel,Ju-Hee Oh,Ann C. Mladek,Surabhi Talele,Wenqiu Zhang,Katie L. Waller,Danielle M. Burgenske,Jann N. Sarkaria,William F. Elmquist

openalex（2024）

引用0浏览0引用

Figure S4 from Delivery Versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant in Vivo Efficacy in Glioblastoma

Wenjuan Zhang,Rachael A. Vaubel,Ju-Hee Oh,Ann C. Mladek,Surabhi Talele,Wenqiu Zhang,Katie L. Waller,Danielle M. Burgenske,Jann N. Sarkaria,William F. Elmquist

openalex（2024）

引用0浏览0引用

Supplementary Table S2 from Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models

Sonia Jain,Jessica I. Griffith,Kendra A. Porath,Sneha Rathi, Jiayan Le, Tugce I. Pasa,Paul A. Decker,Shiv K. Gupta,Zeng Hu,Brett L. Carlson,Katrina Bakken,Danielle M. Burgenske,Thomas M. Feldsien,Didier R. Lefebvre,Rachael A. Vaubel,Jeanette E. Eckel-Passow,Edward B. Reilly,William F. Elmquist,Jann N. Sarkaria

crossref（2024）

引用0浏览0引用

Preclinical Systemic Pharmacokinetics, Dose Proportionality, and Central Nervous System Distribution of the ATM Inhibitor WSD0628, a Novel Radiosensitizer for the Treatment of Brain Tumors

Sneha Rathi,Ju-Hee Oh,Wenjuan Zhang,Ann C. Mladek,Darwin A. Garcia, Zhiyi Xue,Danielle M. Burgenske,Wenqiu Zhang, Jiayan Le, Wei Zhong,Jann N. Sarkaria,William F. Elmquist

The Journal of Pharmacology and Experimental Therapeutics（2024）

引用1浏览0WOS引用

Figure S7 from Delivery Versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant in Vivo Efficacy in Glioblastoma

Wenjuan Zhang,Rachael A. Vaubel,Ju-Hee Oh,Ann C. Mladek,Surabhi Talele,Wenqiu Zhang,Katie L. Waller,Danielle M. Burgenske,Jann N. Sarkaria,William F. Elmquist

openalex（2024）

引用0浏览0引用

Uncovering the Signaling Networks of Disseminated Glioblastoma Cells in Vivo with INSIGHT

Ryuhjin Ahn, D, Lawrence Long,Yufei Cui,Danielle Burgenske,Katrina K Bakken,Lauren L Ott,Brett L Carlson, Grace Zhou,Tomer M Yaron-Barir,Ishwar N Kohale,Charles A Whittaker,Cameron T Flower, Jeffrey Wyckoff,Ann Tuma,Jared L Johnson,Jann Sarkaria,Forest M White

biorxiv（2024）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn